Pharmaceutical composition and methods for using it
Patent 5648397 Issued on July 15, 1997. Estimated Expiration Date: 
March 20, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
March 20, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References 3764672 Methods for controlling perspiration Skin permeation enhancer compositions Patent #: 4568343 InventorApplicationNo. 407451 filed on 03/20/1995US Classes:514/653, Hydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)514/39, Three or more saccharide radicals (e.g., neomycin, etc.)514/169, Cyclopentanohydrophenanthrene ring system DOAI514/170, Plural Compounds containing cyclopentanohydrophenanthrene ring systems514/2001-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)ExaminersPrimary: Dodson, Shelley A.Attorney, Agent or FirmInternational ClassesA61K 031/13A61K 031/70 A61K 031/56 AbstractDisclosed is a pharmaceutical composition intended for the topical application to human skin, comprising(A) as an effective ingredient, a mixture comprising(1) an antibiotic medication;(2) an antihistamine; and(B) a physiologically acceptable carrier.Also disclosed is a method for treatment using this composition.Field of SearchHydroxy, bonded directly to carbon, attached directly or indirectly to the acyclic carbon or chain by acyclic nonionic bonding (e.g., beta hydroxy phenethylamines, etc.)Three or more saccharide radicals (e.g., neomycin, etc.) 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.) Cyclopentanohydrophenanthrene ring system DOAI Plural Compounds containing cyclopentanohydrophenanthrene ring systems | |
